- We will send in 10–14 business days.
/images/books/12405577/9781849736572.jpg)
- Publisher: Royal Society of Chemistry
- Year: 2013
- Pages: 550
- ISBN-10: 184973657X
- ISBN-13: 9781849736572
- Format: 16.5 x 23.8 x 3.8 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
Successful Strategies for the Discovery of Antiviral Drugs (e-book) (used book) | bookbook.eu
Reviews
Description
The antiviral therapeutic area continues to rapidly generate meaningful new chemical entities; for example, for HIV alone more than 25 drugs have been approved, and in the next few years many individual drugs and single tablet regimens will be approved for the treatment of hepatitis C virus infection. The increasing success in the antiviral area could be due to targeting drugs at "non-self" genomes and to the patient population that is tolerant of manageable side effects and adaptable to inconvenient dosing.
Aimed at medicinal chemists and emerging drug discovery scientists, the book is organized according to the various strategies deployed for the discovery and optimization of initial lead compounds. This book focuses on capturing tactical aspects of problem solving in antiviral drug design, an approach that holds special appeal for those engaged in antiviral drug development, but also appeals to the broader medicinal chemistry community based on its focus on tactical aspects of drug design.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 20d.20:09:22
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Royal Society of Chemistry
- Year: 2013
- Pages: 550
- ISBN-10: 184973657X
- ISBN-13: 9781849736572
- Format: 16.5 x 23.8 x 3.8 cm, hardcover
- Language: English English
The antiviral therapeutic area continues to rapidly generate meaningful new chemical entities; for example, for HIV alone more than 25 drugs have been approved, and in the next few years many individual drugs and single tablet regimens will be approved for the treatment of hepatitis C virus infection. The increasing success in the antiviral area could be due to targeting drugs at "non-self" genomes and to the patient population that is tolerant of manageable side effects and adaptable to inconvenient dosing.
Aimed at medicinal chemists and emerging drug discovery scientists, the book is organized according to the various strategies deployed for the discovery and optimization of initial lead compounds. This book focuses on capturing tactical aspects of problem solving in antiviral drug design, an approach that holds special appeal for those engaged in antiviral drug development, but also appeals to the broader medicinal chemistry community based on its focus on tactical aspects of drug design.
Reviews